Researchers
Meet the researchers from Quezon City Science High School
AGLIAM, Nayelli Beatrix S.
FABULA, Jamaica Mishia E.
MABBORANG, Cyrha Angeline T.
MADRAZO, Mary Faith L.
NAVIA, Noelle Marie S.
ATAY Project is composed of a group of young innovators studying at Quezon City Science High School, collaborating with talented professionals and research consultants. This joint team has developed an AI-powered diagnostic tool that revolutionizes early detection of Metabolic dysfunction-Associated Fatty Liver Disease (MAFLD) in young adults by leveraging advanced machine learning algorithms to analyze enzyme biomarkers with unprecedented accuracy.
Their work represents a critical advancement in addressing one of the fastest-growing liver diseases globally, particularly among younger populations, where early intervention can prevent serious complications. The team's interdisciplinary approach brings together computer scientists specializing in web and AI development, clinical researchers with deep expertise in liver disease pathophysiology, and digital health professionals, all united by their commitment to making liver diagnostic capabilities more accessible and affordable. Through ATAY, they are pioneering a new paradigm in preventive medicine that aims to bridge the gap between early detection of MAFLD and the provision of accessible, cost-effective healthcare solutions, one that could transform how we screen, monitor, and manage liver health in young adults, potentially saving countless lives through early detection and intervention.
Their work represents a critical advancement in addressing one of the fastest-growing liver diseases globally, particularly among younger populations, where early intervention can prevent serious complications. The team's interdisciplinary approach brings together computer scientists specializing in web and AI development, clinical researchers with deep expertise in liver disease pathophysiology, and digital health professionals, all united by their commitment to making liver diagnostic capabilities more accessible and affordable. Through ATAY, they are pioneering a new paradigm in preventive medicine that aims to bridge the gap between early detection of MAFLD and the provision of accessible, cost-effective healthcare solutions, one that could transform how we screen, monitor, and manage liver health in young adults, potentially saving countless lives through early detection and intervention.